Brunekreef G A, Kraft H J, Schoenmakers J G, Lubsen N H
Department of Molecular Biology and Cell Biology, University of Nijmegen, The Netherlands.
J Mol Biol. 1996 Oct 11;262(5):629-39. doi: 10.1006/jmbi.1996.0541.
In duck, the housekeeping enzyme lactate dehydrogenase B (LDH-B) and the lens structural protein epsilon-crystallin are encoded by the same single copy gene. Transcription of the gene is initiated from two closely spaced start sites, at -28 and +1. The usage of the downstream site is greatly enhanced in lens. Deletion mapping of the promoter shows that the region -70/+18 specifies the enhanced promoter activity in the lens. A critical role is played by the consensus Sp1 binding site at -50; mutation of this site abolishes lens-preferred expression. Deletion of the +1 transcription initiation site also leads to a decrease in lens-preferred expression, which can be restored by moving the -28 transcription initiation site downstream. By band shift experiments, supershift mobility assays and methylation interference assays, Sp1 was shown to bind to the Sp1 consensus binding site at -50 using either heart or lens nuclear extracts. Co-expression of Sp1 or Sp1-like factors inhibited the activity of an LDH-B/epsilon-crystallin promoter construct by approximately 60% in lens and by 40% in heart cells. Co-expression of Pax-6, a transcription factor shown to be involved in the lens-enhanced expression of a number of other crystallin genes, did not influence the promoter activity of the -130/+650 LDH-B/epsilon-crystallin promoter construct. In contrast to other crystallin promoters, the LDH-B/epsilon-crystallin promoter does not appear to contain a lens-specific element, rather our data lead to a model in which a factor transmitting the effect of Sp1, bound at -50, to the transcription initiation complex is responsible for the lens-preferred expression of the LDH-B/epsilon-crystallin promoter.
在鸭中,管家酶乳酸脱氢酶B(LDH - B)和晶状体结构蛋白ε - 晶体蛋白由同一个单拷贝基因编码。该基因的转录从两个紧密相邻的起始位点开始,分别位于-28和+1处。下游位点的使用在晶状体中显著增强。启动子的缺失图谱显示,-70 / +18区域决定了晶状体中增强的启动子活性。-50处的共有Sp1结合位点起着关键作用;该位点的突变消除了晶状体偏好性表达。+1转录起始位点的缺失也导致晶状体偏好性表达降低,将-28转录起始位点向下游移动可恢复这种表达。通过凝胶迁移实验、超迁移率分析和甲基化干扰分析表明,使用心脏或晶状体核提取物时,Sp1都能与-50处的Sp1共有结合位点结合。Sp1或Sp1样因子的共表达在晶状体中使LDH - B / ε - 晶体蛋白启动子构建体的活性降低约60%,在心脏细胞中降低约40%。已证明参与许多其他晶体蛋白基因晶状体增强表达的转录因子Pax - 6的共表达,并不影响-130 / +650 LDH - B / ε - 晶体蛋白启动子构建体的启动子活性。与其他晶体蛋白启动子不同,LDH - B / ε - 晶体蛋白启动子似乎不包含晶状体特异性元件,相反,我们的数据得出一个模型,其中一个将结合在-50处的Sp1的效应传递给转录起始复合物的因子,负责LDH - B / ε - 晶体蛋白启动子的晶状体偏好性表达。